WHEN YOU CAN CALCULATE THE NPV
               FOR AN R&D PRODUCT IN SECONDS,

                                   THAT'S INTELLIGENCE YOU CAN ACT ON.

                                                                            Learn more



                                             WHEN YOU CAN TRACK THE KEY EVENTS
                   THAT IMPACT A PRODUCT OR COMPANY'S VALUATION,

    THAT'S INTELLIGENCE YOU CAN ACT ON.

                                                                           Learn more

WHEN YOU CAN EASILY DETERMINE
THAT A NEW THERAPY CATEGORY
IS A MARKET OPPORTUNITY,







THAT'S INTELLIGENCE YOU CAN ACT ON.

    

Learn more

Select ImageSelect ImageSelect Image
Page BannerPage BannerPage Banner

Service Temporarily Unavailable

Our team are currently in the process of updating the security we have installed on the site. Please be patient as we hope to have our service running again very soon.

Market intelligence leader in consensus forecasts and analysis of the life science industry

Biotechnology | Pharmaceutical | Medical Device | Diagnostic

Explore Evaluate Premier Services:

March 05, 2013

Leader in consensus forecast analysis of the biotech and pharma sector providing trusted insight into global performance to 2018. March 05, 2013

New standard in integrated analysis and consensus forecasts to 2018 of the medical device and diagnostic industry. March 05, 2013

Unique clinical trial intelligence integrated and standardized to efficiently analyze the global clincial trial landscape.
March 05, 2013
Explore EvaluatePharma Explore EvaluateMedTech Explore EvaluateClinical Trials

Award-winning daily commentary and analysis with fresh perspectives and insight into current and future industry trends.

March 05, 2013
Explore EPVantage

March 06, 2013

Evaluate Reports

EvaluatePharma Orphan Drug Report 2013: Worldwide Orphan Drug Market to Grow to $127 Billion by 2018

Download Report
View Infographic 
Press Release

EP Vantage 2012 Year in Review : Pharma Boom or Bust?
Download Report
More News and Insight 

Find value faster with Evaluate

  • Consensus forecasts to 2018
  • High quality, transparent data   
  • Standardized, dynamic platform   
  • Evaluation tools and custom exports
  • Friendly, expert support

Request a demo

What our customers are saying

When I think of the future, I think of EvaluatePharma 

Senior Director,
Global pharmaceutical company

Read more customer testimonials

March 06, 2013